Outlook Therapeutics, Inc. · NASDAQ:OTLK

Thurman Randy H bought 5,000 Outlook Therapeutics, Inc. shares (Form 4)

Traded May 26, 2026 · Filed May 27, 2026

On May 26, 2026, Thurman Randy H (Director) bought 5,000 Outlook Therapeutics, Inc. shares at US$0.43 for US$2,150, leaving 5,593 shares. Filed May 27, 2026 (Form 4).

Bought
5,000 shares
Price
US$0.43
Value
US$2,150
Holding after
5,593 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 26, 2026Common StockBuy5,000US$0.435,593Direct

Source

View original at SEC

Related